Cannara fait le point sur les documents relatifs à l’assemblée générale annuelle de 2024 dans le contexte de la grève de Postes Canada MONTRÉAL, 16 déc. 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), un producteur verticalement...

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike Cannara announces its 2024 AGM will be virtual. Due to a postal strike. Proxy materials are online, and exemptions apply under CSA Blanket Order 51-913

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market Cannara Biotech reports record FY2024 revenue of $82.2M (+43%), strong Q4 growth, 3.2% national market share, and plans for expanded production.

OxySure (OXYS) Improves Bottom Line as It Ramps Up Revenues FRISCO, Texas, Aug. 21, 2012 (GLOBE NEWSWIRE) -- OxySure Systems Inc. (OTCBB:OXYS), a medical technology company focused on the design, manufacture and distribution of specialty medical and...